Understand the source comparison
Inflammation Modulation vs Suppression — A Critical Distinction
Conventional anti-inflammatory protocols (NSAIDs, corticosteroid injections) suppress cyclooxygenase enzymes and reduce prostaglandin production, which lowers pain signaling but also blunts the inflammatory phase that's required for tissue repair initiation. E
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Conventional anti-inflammatory protocols (NSAIDs, corticosteroid injections) suppress cyclooxygenase enzymes and reduce prostaglandin production, which lowers pain signaling but also blunts the inflammatory phase that's required for tissue repair initiation. Early NSAID use has been associated with delayed healing and reduced collagen deposition in multiple animal models. The inflammation isn't a problem to eliminate, it's a signal cascade that must resolve correctly.
- GHK-Cu doesn't suppress inflammation. It modulates the transition from pro-inflammatory to anti-inflammatory cytokine dominance. Copper is a cofactor for lysyl oxidase, the enzyme that cross-links collagen fibers to create tensile strength. GHK-Cu has been shown to reduce IL-6 and TNF-alpha levels while increasing anti-inflammatory IL-10, shifting the tissue environment from catabolic breakdown to anabolic repair. A study published in Wound Repair and Regeneration found that GHK-Cu increased collagen synthesis in dermal wounds by 70% compared to controls, primarily through TGF-beta pathway modulation.
- The peptide's mechanism also includes upregulation of decorin, a proteoglycan that organizes collagen fibers and prevents excessive scar tissue formation. This is the biological reason why some healed tendons feel stiff and restricted. The collagen was deposited but never organized correctly along the load axis. GHK-Cu addresses the structural quality of the repair, not just the quantity of new tissue.